Hepatitis B Topics HBV Treatment
Heavy Alcohol Use Increases Liver Cancer Risk in Hepatitis B Patients with Cirrhosis
- Details
- Category: HBV Treatment
- Published on Wednesday, 24 April 2013 00:00
- Written by Liz Highleyman
Heavy drinking can add to the already elevated likelihood that people with liver cirrhosis related to hepatitis B virus (HBV) infection will develop hepatocellular carcinoma (HCC), according to a study published in the April 2013 Journal of Hepatology.
EASL International Liver Congress Starts this Week in Amsterdam
- Details
- Category: HBV Treatment
- Published on Monday, 22 April 2013 00:00
- Written by Liz Highleyman
The 
48th Annual Meeting of the European Association for the Study of the Liver (EASL 2013) kicks off this Wednesday, April 24, at the Amsterdam RAI congress center. HIVandHepatitis.com will be on site to provide breaking news and analysis starting later this week.
Antioxidant N-acetylcysteine Improves Survival of Transplanted Liver
- Details
- Category: HBV Treatment
- Published on Thursday, 28 February 2013 00:00
- Written by Liz Highleyman
N-acetylcysteine (NAC) administered during recovery of a liver from a deceased donor can help reduce damage during transplantation and increase survival of the liver graft in the recipient, according to a study published in the February 19, 2013, issue of Liver Transplantation.
CROI 2013: Dually Active Antiretroviral Therapy Protects Against Primary Hepatitis B Infection
- Details
- Category: HBV Treatment
- Published on Wednesday, 06 March 2013 00:00
- Written by Liz Highleyman
Use of antiretroviral therapy (ART) that includes drugs active against both hepatitis B virus (HBV) and HIV reduces the risk that HIV positive people will become infected with HBV -- in effect acting as HBV PrEP -- according to a study presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this week in Atlanta.
Most Hepatitis B Patients Who Respond to Tenofovir Show Improved Liver Health at 5 Years
- Details
- Category: HBV Treatment
- Published on Thursday, 27 December 2012 00:00
- Written by Liz Highleyman
Treatment with tenofovir (Viread) remains safe and effective over 5 years, and people who achieve sustained viral load suppression experience improvement in liver histology, including regression of fibrosis and cirrhosis, according to study findings described in the December 7, 2012, advance online edition of The Lancet.
More Articles...
- AASLD 2012: Entecavir Shows Good Efficacy for Black and Hispanic Hepatitis B Patients
- AASLD 2012: Adding Pegylated Interferon to Entecavir Improves HBV Treatment Response
- FDA: Do Not Mix Hepatitis B Drug Adefovir with Stribild HIV Combo Pill
- AASLD 2012: Nucleoside Analogs Reduce Hepatitis B Liver Cancer Risk, Cirrhosis Remains a Concern
Web Design and Development by